Otc - Active Ingredient
Active IngredientSalicylic Acid 2%
Purpose
Acne treatment
The following Structured Product Label (SPL) was submitted to the FDA by Guangzhou Yapheon Health Industry Co., Ltd. for the product Orlaskin Salicylic Acid Acne Treatment Pads (NDC 87582-006). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.
This specific version of the label includes detailed information regarding otc - active ingredient, otc - purpose, otc - keep out of reach of children, dosage & administration, warnings, indications & usage, inactive ingredient, package label.principal display panel, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.
Active IngredientSalicylic Acid 2%
Purpose
Acne treatment
Uses
for the treatment of acneclears up acne pimples
helps keep skin clear of new acne pimples
Keep out of reach of childrenIf swallowed, get medical help or contact a Poison Control Center right away.
wipe the entire affected area with one pad
because excessive drying of the skin may occur, start with one application daily, then gradually increase to two or three times
For external use only
Directions
cleanse the skin thoroughly before applying this product
wipe the entire affected area with one pad
because excessive drying of the skin may occur, start with one application daily, then gradually increase to two or three times
daily if needed or as directed by a doctor
if bothersome dryness or peeling occurs, reduce application to once a day or every other day
Other information Keep tightly closed store in a cool & dry place
Inactive Ingredients
Purified Water, Propanediol,Aloe Barbadensis Leaf Juice, Niacinamide, Butylene Glycol, Hamamelis Virginiana (WitchHazel) Water, PEG-40 Hydrogenated Castor Oil, Panthenol, Polysorbate 20, Phenoxyethanol, Ethylhexylglycerin, Zinc
PCA, Allantoin, Hydroxyacetophenone, Citric Acid, Sodium Citrate, Disodium EDTA
* Please review the disclaimer below.